Thornton & Ross News

Thornton & Ross Ltd acquires Natures Aid Ltd

November 2016
Thornton & Ross Ltd, based in Huddersfield, is pleased to announce that it has acquired the Natures Aid business, a leading UK manufacturer and distributor of premium quality branded vitamins, minerals, food supplements and herbal products. Founded in 1981, Natures Aid is based in Preston, Lancashire, where it employs approximately 60 staff and has particular expertise in the manufacture of tablets and capsules, with significant distribution in the health food store sector, as well as in on-line retailing.

Commenting on the purchase, Barry Draude, the Managing Director of Thornton & Ross, said that the Natures Aid business would bring exciting new opportunities to both companies, as well as the broader STADA Group, T&R's parent company. Mr Draude added that there are a number of potential portfolio synergies between T+R and Natures Aid, which could be exploited quite quickly.

Thornton & Ross Ltd. manufactures and markets a range of consumer and prescription medical products, including Covonia cough medicines, Hedrin head lice treatment, the Care range of medicines, the Cetraben and Zero dermatological brands, Flexitol footcare products and the Fultium range of Vitamin D3 products via its Internis subsidiary. The business is part of STADA Arzneimittel AG which is based in Bad Vilbel, Germany.

Dieno George, STADA Executive Vice President with responsibility for branded products, commented that the acquisition of Natures Aid continued STADA's strategy of building their branded offering with high quality products which offer potential for internationalisation through STADA affiliates across Europe.

Further information can be obtained from:

Mr Barry Draude
Managing Director
Thornton & Ross Ltd.

Tel: 01484 842217


STADA to Become a Major Pharma Player in Ukraine by Acquiring Biopharma's Pharmaceutical Prescription and Consumer Health Business

The STADA Group continues its growth trajectory in Europe. The company, announced that it is acquiring the pharmaceutical business of Biopharma, one of the key pharmaceutical producers in Ukraine.

Click for more info

Is veganism good for your health?

The Future of Your Health report indicates that nearly a third of Brits don’t think so

Click for more info


Biopharmaceutical company Alvotech and global pharmaceutical company STADA Arzneimittel AG ("STADA") today announced that they have entered into an exclusive strategic partnership for the commercialisation of seven biosimilars in all key European markets and selected markets outside Europe.

Click for more info

STADA invests $660 Million USD in Takeda's OTC portfolio in Russia/CIS to become a major player in these branded markets

STADA to acquire a portfolio of approximately 20 selected OTC and prescription pharmaceutical products in Russia, Georgia and CIS countries

Click for more info

STADA to acquire Walmark - a leading Consumer Healthcare company in Central Europe

STADA Arzneimittel AG ('STADA' or 'the Group') today announces the acquisition of Walmark a.s. ('Walmark' or 'the company') from Mid Europa Partners for an undisclosed consideration.

Click for more info

Q&A 2019 Pharmacy Show

A Q&A Session with Phoebe Buckley on the 2019 Pharmacy Show

Click for more info

STADA Health Report 2019

More than half of people in UK are optimistic about the future of health

Click for more info

Leading pharmaceutical company invests in seven-figure state-of-the-art facility

Huddersfield pharmaceutical company Thornton & Ross is expanding, with a new seven-figure state-of-the-art facility due to open at the beginning of January.

Click for more info

>> News Archive